Chongqing Xishan Science&Technology Co. Ltd. A
Chongqing Xishan Science & Technology Co., Ltd. engages in the research and development, manufacturing, sale, and service of digital minimally invasive surgical equipment and medical consumables in China and internationally. The company offers powered surgical instruments, such as micromotor, handpiece, attachment, shaver, bur, saw blade, and perforator; vacuum-assisted breast biopsy, including c… Read more
Chongqing Xishan Science&Technology Co. Ltd. A (688576) - Net Assets
Latest net assets as of June 2025: CN¥1.71 Billion CNY
Based on the latest financial reports, Chongqing Xishan Science&Technology Co. Ltd. A (688576) has net assets worth CN¥1.71 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.85 Billion) and total liabilities (CN¥142.76 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.71 Billion |
| % of Total Assets | 92.29% |
| Annual Growth Rate | 75.64% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 202.66 |
Chongqing Xishan Science&Technology Co. Ltd. A - Net Assets Trend (2021–2024)
This chart illustrates how Chongqing Xishan Science&Technology Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Chongqing Xishan Science&Technology Co. Ltd. A (2021–2024)
The table below shows the annual net assets of Chongqing Xishan Science&Technology Co. Ltd. A from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.77 Billion | -18.31% |
| 2023-12-31 | CN¥2.16 Billion | +431.54% |
| 2022-12-31 | CN¥406.49 Million | +24.83% |
| 2021-12-31 | CN¥325.65 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Chongqing Xishan Science&Technology Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 23896.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥221.92 Million | 12.57% |
| Other Components | CN¥1.54 Billion | 87.43% |
| Total Equity | CN¥1.77 Billion | 100.00% |
Chongqing Xishan Science&Technology Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Chongqing Xishan Science&Technology Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zhejiang Golden Eagle Co Ltd
SHG:600232
|
$217.11 Million |
|
Ha Do Group JSC
VN:HDG
|
$217.13 Million |
|
FAMUR S.A. ZY 001
F:8MF
|
$217.14 Million |
|
Bestore Co Ltd
SHG:603719
|
$217.17 Million |
|
Amper S.A.
PINK:APMRF
|
$216.95 Million |
|
Alphamin Resources Corp
PINK:AFMJF
|
$216.87 Million |
|
Highbroad Advanced Material (Hefei) Co. Ltd. A
SHE:301321
|
$216.85 Million |
|
Polyrocks Chemical Co Ltd
SHG:688669
|
$216.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chongqing Xishan Science&Technology Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,160,657,294 to 1,765,030,667, a change of -395,626,628 (-18.3%).
- Net income of 98,666,904 contributed positively to equity growth.
- Dividend payments of 48,884,689 reduced retained earnings.
- Other factors decreased equity by 445,408,843.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥98.67 Million | +5.59% |
| Dividends Paid | CN¥48.88 Million | -2.77% |
| Other Changes | CN¥-445.41 Million | -25.24% |
| Total Change | CN¥- | -18.31% |
Book Value vs Market Value Analysis
This analysis compares Chongqing Xishan Science&Technology Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.12x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 9.22x to 2.12x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | CN¥8.19 | CN¥75.50 | x |
| 2022-12-31 | CN¥10.23 | CN¥75.50 | x |
| 2023-12-31 | CN¥40.77 | CN¥75.50 | x |
| 2024-12-31 | CN¥35.57 | CN¥75.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chongqing Xishan Science&Technology Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.59%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 29.33%
- • Asset Turnover: 0.17x
- • Equity Multiplier: 1.09x
- Recent ROE (5.59%) is below the historical average (12.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 18.86% | 29.41% | 0.52x | 1.24x | CN¥28.86 Million |
| 2022 | 18.54% | 28.73% | 0.50x | 1.29x | CN¥34.70 Million |
| 2023 | 5.43% | 32.53% | 0.16x | 1.07x | CN¥-98.72 Million |
| 2024 | 5.59% | 29.33% | 0.17x | 1.09x | CN¥-77.84 Million |
Industry Comparison
This section compares Chongqing Xishan Science&Technology Co. Ltd. A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,246,530,775
- Average return on equity (ROE) among peers: 12.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chongqing Xishan Science&Technology Co. Ltd. A (688576) | CN¥1.71 Billion | 18.86% | 0.08x | $217.07 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $760.18 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.33 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $360.97 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $242.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $802.27 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $556.14 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.61 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |